Protein arylation precedes acetaminophen toxicity in a dynamic organ slice culture of mouse kidney

被引:13
作者
Hoivik, DJ
Fisher, RL
Brendel, K
Gandolfi, AJ
Khairallah, EA
Cohen, SD
机构
[1] UNIV CONNECTICUT, SCH PHARM, DEPT PHARMACEUT SCI, STORRS, CT 06269 USA
[2] UNIV CONNECTICUT, DEPT MOL & CELL BIOL, STORRS, CT 06269 USA
[3] UNIV ARIZONA, DEPT PHARMACOL, TUCSON, AZ 85724 USA
[4] UNIV ARIZONA, DEPT ANESTHESIOL, TUCSON, AZ 85724 USA
来源
FUNDAMENTAL AND APPLIED TOXICOLOGY | 1996年 / 34卷 / 01期
关键词
D O I
10.1006/faat.1996.0180
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Acetaminophen (APAP) is an analgesic and antipyretic agent which may cause hepatotoxicity and nephrotoxicity with overdose in man and laboratory animals. In vivo studies suggest that in situ activation of APAP contributes to the development of nephrotoxicity. Associated with target organ toxicity is selective arylation of proteins, with a 58-kDa acetaminophen binding protein (58-ABP) being the most prominent cytosolic target. In this study a mouse kidney slice model was developed to further evaluate the contribution of in situ activation of APAP to the development of nephrotoxicity and to determine the selectivity of protein arylation. Precision cut kidney slices from male CD-1 mice were incubated with selected concentrations of APAP (0-25 mM) for 2 to 24 hr. APAP caused a dose- and time-dependent decrease in nonprotein sulfhydryls (NPSH), ATP content, and K+ retention. Preceding toxicity was arylation of cytosolic proteins, the most prominent one being the 58-ABP. The association of 58-ABP arylation with APAP toxicity in this mouse kidney slice model is consistent with earlier, in vivo results and demonstrates the importance of in situ activation of APAP for the development of nephrotoxicity. Precision cut renal slices and dynamic organ culture are a good model for further mechanistic studies of APAP-induced renal toxicity. (C) 1996 Society of Toxicology.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 39 条
[1]  
Anker Anthony L., 1994, Emergency Medicine Clinics of North America, V12, P335
[2]   SELECTIVE ACETAMINOPHEN METABOLITE BINDING TO HEPATIC AND EXTRAHEPATIC PROTEINS - AN INVIVO AND INVITRO ANALYSIS [J].
BARTOLONE, JB ;
BEIERSCHMITT, WP ;
BIRGE, RB ;
HART, SGE ;
WYAND, S ;
COHEN, SD ;
KHAIRALLAH, EA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 99 (02) :240-249
[3]   IMMUNOCHEMICAL DETECTION OF ACETAMINOPHEN-BOUND LIVER PROTEINS [J].
BARTOLONE, JB ;
SPARKS, K ;
COHEN, SD ;
KHAIRALLAH, EA .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (08) :1193-1196
[4]   IMMUNOCHEMICAL ANALYSIS OF ACETAMINOPHEN COVALENT BINDING TO PROTEINS - PARTIAL CHARACTERIZATION OF THE MAJOR ACETAMINOPHEN-BINDING LIVER PROTEINS [J].
BARTOLONE, JB ;
BIRGE, RB ;
SPARKS, K ;
COHEN, SD ;
KHAIRALLAH, EA .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4763-4774
[5]   SELECTIVE PROTEIN ARYLATION AND THE AGE DEPENDENCY OF ACETAMINOPHEN HEPATOTOXICITY IN MICE [J].
BEIERSCHMITT, WP ;
BRADY, JT ;
BARTOLONE, JB ;
WYAND, DS ;
KHAIRALLAH, EA ;
COHEN, SD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 98 (03) :517-529
[6]   ACETAMINOPHEN HEPATOTOXICITY - CORRESPONDENCE OF SELECTIVE PROTEIN ARYLATION IN HUMAN AND MOUSE-LIVER INVITRO, IN CULTURE, AND INVIVO [J].
BIRGE, RB ;
BARTOLONE, JB ;
HART, SGE ;
NISHANIAN, EV ;
TYSON, CA ;
KHAIRALLAH, EA ;
COHEN, SD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 105 (03) :472-482
[7]   LIVER NECROSIS FROM PARACETAMOL [J].
BOYD, EM ;
BERECZKY, GM .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (03) :606-&
[8]   ACETAMINOPHEN-INDUCED HEPATIC NECROSIS AND RENAL FAILURE [J].
BOYER, TD ;
ROUFF, SL .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 218 (03) :440-&
[9]  
BURCHAM PC, 1991, J BIOL CHEM, V266, P5049
[10]   INHIBITION OF CEPHALORIDINE-INDUCED LIPID-PEROXIDATION [J].
COJOCEL, C ;
LAESCHKE, KH ;
INSELMANN, G ;
BAUMANN, K .
TOXICOLOGY, 1985, 35 (04) :295-305